Novo Nordisk A/S Stock Price and Value Analysis

Should you buy Novo Nordisk A/S stock? (NYSE:NVO). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company has an average dividend yield.
  • This company has amazingly consistent growth!
  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.

Inside the NVO Numbers

NVO Price
(Novo Nordisk A/S stock price per share)
$48.39
[?] PE Ratio versus Sector 6% lower than other Healthcare stocks
[?] PE Ratio versus Industry 67% lower than other Biotechnology stocks
[?] Free Cash Flow Jitter 0%
[?] Dividend Yield 2%

Is Novo Nordisk A/S Stock on Sale?

Based on our analysis, we believe that you should not buy Novo Nordisk A/S right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy NVO Stock?

Does Novo Nordisk A/S have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.